Biopharmaceutical Manufacturing Preparedness-Consortium (BioMaP–Consortium)

The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response, is seeking a Consortium Management Firm (CMF) to establish and manage the Biopharmaceutical Manufacturing Preparedness-Consortium (BioMaP–Consortium). Under the guidance of the BioMaP Branch, the selected firm will handle the day-to-day technical, programmatic, financial, and administrative operations of the consortium. Key responsibilities include soliciting, awarding, and managing project agreements and sub-agreements for consortium members to support biopharmaceutical manufacturing preparedness.

This solicitation, identified by number 75A50123D00003, is classified under NAICS code 325414 for Biological Product (except Diagnostic) Manufacturing and PSC code AN42 for Health R&D Services; Health Care - Other; Applied Research. Formal responses to the solicitation are due by 3:00 PM Eastern on August 22, 2023, following earlier deadlines for questions and notices of intent. Documentation for this opportunity includes a statement of objectives, the full solicitation text, and an amendment providing responses to industry questions.

All submissions and communications regarding this requirement are directed to the point of contact, Shane Sarchiapone. The procurement is managed by the BARDA Division of Contracts management and Acquisition (DCMA). No specific set-aside was designated in the provided notice metadata.